These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7979606)

  • 1. Biological therapy of sepsis.
    Norton JA
    Ann Surg; 1994 Nov; 220(5):599-600. PubMed ID: 7979606
    [No Abstract]   [Full Text] [Related]  

  • 2. Earlier methods of antibiotics administered prophylactically perioperatively.
    Lord JW
    Ann Surg; 1995 Nov; 222(5):689-90. PubMed ID: 7487219
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.
    Tzianabos AO; Gibson FC; Cisneros RL; Kasper DL
    J Infect Dis; 1998 Jul; 178(1):200-6. PubMed ID: 9652441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of beta-1,3-glucan to prevent shipping fever in imported heifers.
    Pedroso M
    Arch Med Res; 1994; 25(2):181. PubMed ID: 7919809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological aspects of postoperative sepsis].
    Beloborodova NV; Bachinskaia EN
    Anesteziol Reanimatol; 2000; (1):59-66. PubMed ID: 10769474
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.
    Babineau TJ; Marcello P; Swails W; Kenler A; Bistrian B; Forse RA
    Ann Surg; 1994 Nov; 220(5):601-9. PubMed ID: 7979607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan).
    de Felippe Júnior J; da Rocha e Silva Júnior M; Maciel FM; Soares Ade M; Mendes NF
    Surg Gynecol Obstet; 1993 Oct; 177(4):383-8. PubMed ID: 8211583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxemia is masked in fungal infection due to enhanced endotoxin clearance by beta-glucan.
    Yokota M; Tsujinaka T; Kambayashi J; Watase M; Sakon M; Mori T
    Int Surg; 1991; 76(4):255-60. PubMed ID: 1778725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of leukinferon in suppurative-septic diseases].
    Spivak NIa; Ganova LA; Iakovenko LF; Kravchuk BA; Makarov AV; Krivokhatskaia LD; Simonova AA; Belotskiĭ SM
    Klin Khir (1962); 1994; (5):56-8. PubMed ID: 7807907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement function in mAb-mediated cancer immunotherapy.
    Gelderman KA; Tomlinson S; Ross GD; Gorter A
    Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-1,3-glucan and other immunomodulators in experimental leprosy infection in mice].
    Delville J; Jacques PJ
    Acta Leprol; 1979; (76-77):273-81. PubMed ID: 121844
    [No Abstract]   [Full Text] [Related]  

  • 12. The Toll of sepsis: altered innate immunity in polymicrobial sepsis.
    Cook JA
    Crit Care Med; 2003 Jun; 31(6):1880-2. PubMed ID: 12794444
    [No Abstract]   [Full Text] [Related]  

  • 13. [beta-1, 3 glucan as an immunopotentiator against experimental tuberculous infection in mice (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1980 Aug; 55(8):371-4. PubMed ID: 7420811
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthrax-protective effects of yeast beta 1,3 glucans.
    Kournikakis B; Mandeville R; Brousseau P; Ostroff G
    MedGenMed; 2003 Mar; 5(1):1. PubMed ID: 12827062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunotropic properties of I-->3; I-->6-beta-D-glucans].
    Besednova NN; Ivanushko LA; Zviagintseva TN; Eliakova LA
    Antibiot Khimioter; 2000; 45(2):37-44. PubMed ID: 10707805
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental studies on the use of an immunoadjuvant (beta-1, 3 glucan) to prevent relapse after termination of chemotherapy in mouse model (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1980 Sep; 55(9):411-4. PubMed ID: 7431726
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of glucan and other immunopharmacological agents in the prevention and treatment of acute radiation injuries.
    Patchen ML; Chirigos MA; Brook I
    Fundam Appl Toxicol; 1988 Nov; 11(4):573-4. PubMed ID: 3229582
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucans: A Therapeutic Alternative for Sepsis Treatment.
    Viana JPM; Costa FF; Dias TG; Mendes PM; Copeland GB; Nascimento WS; Mendes SSN; Figueiredo IFS; Fernandes ES; Bocca AL; Maciel MCG
    J Immunol Res; 2024; 2024():6876247. PubMed ID: 38939744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of protozoan diseases. Potential of glucan as an adjuvant.
    Cook JA; Runey GL; Holbrook TW
    Surv Immunol Res; 1983; 2(3):243-5. PubMed ID: 6675146
    [No Abstract]   [Full Text] [Related]  

  • 20. Maitake extracts and their therapeutic potential.
    Mayell M
    Altern Med Rev; 2001 Feb; 6(1):48-60. PubMed ID: 11207456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.